|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Aileron Therapeutics, Inc.
| | | Phone: | (617) 995-0900 | Fax: | (617) 995-2410 | Year Established: | 2001 | Ticker: | ALRN | Exchange: | NASDAQ | Main Contact: | Manuel Aivado, MD, Ph.D., President & CEO | | Other Contacts: | Don Dougherty, CPA, CFA, Senior VP & CFO Kira A. Nelson, CPA, VP, Finance & Operations D. Allen Annis, Ph.D., VP, Biophysical and Analytical Technologies
| | Company Description | Aileron Therapeutics (formerly Renegade Therapeutics) is a clinical-stage biopharmaceutical company advancing stapled peptides, a novel class of therapeutics for cancers and other diseases. Stapled peptides are chemically stabilized alpha-helical peptides that are modified to improve their stability and cell penetrability while maintaining high affinity for large protein surfaces. | |
|
|
|
|
|